Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieron Dunleavy

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Blood|March 25, 2017
Unraveling Castleman: progress in a complex processKieron Dunleavy
Journal of Oncology Practice|August 11, 2017
Adult T-Cell Lymphoma/Leukemia: Novel Biologic Insights and New Directions in TreatmentKieron Dunleavy
The Lancet. Oncology|February 23, 2016
Immunomodulatory agents in mantle cell lymphomaKieron Dunleavy
British Journal of Haematology|September 7, 2019
Epigenetic targeting in mantle cell lymphomaKieron Dunleavy
Leukemia & Lymphoma|August 18, 2012
Advancing therapeutics in human immunodeficiency virus-associated lymphoma: where to go from here?Kieron Dunleavy
Hematology. American Society of Hematology. Education Program|February 20, 2015
Double-hit lymphomas: current paradigms and novel treatment approachesKieron Dunleavy
Hematology/Oncology Clinics of North America|June 24, 2019
Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 RearrangementsRami Alsharif, Kieron Dunleavy
Leukemia & Lymphoma|October 27, 2012
Tackling Burkitt lymphoma in older patients: novel strategies and the promise of targeted agentsCatherine Lai, Kieron Dunleavy
Best Practice & Research. Clinical Haematology|June 18, 2013
NK/T-cell lymphomas in childrenCatherine Lai, Kieron Dunleavy
Blood|August 16, 2020
How I treat lymphoma in pregnancyKieron Dunleavy, Claire McLintock
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Blood|March 25, 2017
Unraveling Castleman: progress in a complex processKieron Dunleavy
Journal of Oncology Practice|August 11, 2017
Adult T-Cell Lymphoma/Leukemia: Novel Biologic Insights and New Directions in TreatmentKieron Dunleavy
The Lancet. Oncology|February 23, 2016
Immunomodulatory agents in mantle cell lymphomaKieron Dunleavy
British Journal of Haematology|September 7, 2019
Epigenetic targeting in mantle cell lymphomaKieron Dunleavy
Leukemia & Lymphoma|August 18, 2012
Advancing therapeutics in human immunodeficiency virus-associated lymphoma: where to go from here?Kieron Dunleavy
Hematology. American Society of Hematology. Education Program|February 20, 2015
Double-hit lymphomas: current paradigms and novel treatment approachesKieron Dunleavy
Hematology/Oncology Clinics of North America|June 24, 2019
Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 RearrangementsRami Alsharif, Kieron Dunleavy
Leukemia & Lymphoma|October 27, 2012
Tackling Burkitt lymphoma in older patients: novel strategies and the promise of targeted agentsCatherine Lai, Kieron Dunleavy
Best Practice & Research. Clinical Haematology|June 18, 2013
NK/T-cell lymphomas in childrenCatherine Lai, Kieron Dunleavy
Blood|August 16, 2020
How I treat lymphoma in pregnancyKieron Dunleavy, Claire McLintock
Pageof 13